A clinical trial is investigating whether a stem cell-derived patch can replace disease-damaged cells and restore vision. Age-related macular degeneration is a steadily worsening eye disease and the ...

People with macular degeneration and other forms of central vision loss can see details like text and faces with this device.

Folks with central-vision loss can judge the motion of vehicles almost as accurately as people with normal vision, ...

编者按：年龄相关性黄斑变性（AMD）是一种严重的眼部疾病，患者会逐渐失去中央视野甚至可能失明。文献数据显示，全球受AMD困扰的人群接近2亿。早期医学界缺乏阻止AMD进展的有效手段，近年来各类靶向疗法的出现改善了这一局面，此外多种创新疗法正处于研发阶段 ...

In July 2025, Novartis Pharmaceuticals conducted a study is to assess the effect of Iptacopan to prevent conversion of early ...

The AMD market is expected to grow at a CAGR of 10.2% over the course of the forecast period (2024–34), reaching $20.5bn ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with diabetes, ...

Macular Society: "Smoking and sight loss." NYU Langone Health: "Lifestyle Changes for Macular Degeneration." American Optometric Association: "Diet and Nutrition." Macular Degeneration Association: ...

What is age-related macular degeneration? Age-related macular degeneration is a condition of the macula, a tiny area of the retina at the back of the eye. Your macula is only about the size of the ...

Outlook Therapeutics shares slid after the company's macular degeneration drug was once again rejected by the Food and Drug Administration. The stock dropped 71% to 45 cents a share in after-hours ...